Chronic pain patients with legal access to medicinal cannabis significantly decrease their use of opioids, according to data published online ahead of print in The Journal of Pain. “Among study participants, medical cannabis use was associated with a 64% decrease in opioid use, decreased number and side effects of medications, and an improved quality of life,” investigators concluded.
The long-term, daily use of cannabis is associated with improved analgesia and reduced opioid use in patients with treatment-resistant chronic pain conditions, according to clinical trial data reported online ahead of print in The Clinical Journal of Pain.
[Editor’s note: This post is excerpted from this week’s forthcoming NORML weekly media advisory. To…
With New Jersey recently becoming the 14th medical marijuana state, activists in marijuana law reform have been celebrating.
Set in an older blue-collar neighborhood in North East Portland, NORML’s Cannabis Café, occupies a building that was reputed to be a ‘speakeasy’ during Prohibition, alcohol Prohibition, that is. It includes a meeting/concert space upstairs for about 200+ people, in addition to the Café downstairs.
A funny thing happens when the US government begrudgingly allows for double-blind, placebo-controlled clinical trials evaluating the therapeutic efficacy of inhaled cannabis.
Investigators discover time after time that it works!